Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta‐analysis
Open Access
- 7 December 2007
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 263 (1) , 52-60
- https://doi.org/10.1111/j.1365-2796.2007.01878.x
Abstract
Objectives. Venous thromboembolism (VTE) is a potentially serious complication of hospitalization and immobilization. The use of anticoagulant prophylaxis in acutely ill medical inpatients is still under debate. New data including a recent meta‐analysis have recently been published. We aim at studying the efficacy and safety of anticoagulant prophylaxis in acutely ill medical inpatients, and demonstrate differences between meta‐analyses due to different data extraction from the heterogeneous studies included. Subjects. The Cochrane Library, MEDLINE and EMBASE were searched from 1980 to present. Manual searches were performed regarding abstracts from major meetings. Seven blinded randomized controlled clinical trials assessing the prophylactic effect of heparin in acutely ill medical patients were identified and included in the meta‐analysis. Results. Low‐molecular weight heparin (LMWH) prophylaxis prevented 48% of symptomatic pulmonary embolism (PE), 48% of symptomatic deep vein thrombosis (DVT) (not significant) and 51% of asymptomatic DVT. A nonsignificant trend towards higher bleeding risk during LMWH prophylaxis was found. Death was not significantly affected. We compared our data with a recent meta‐analysis with different study selection and data extraction and found similar results. Conclusions. As DVT and PE are manifestations of the same illness, VTE, one can argue that anticoagulant prophylaxis prevents approximately half of the expected events. Most medical inpatients have short hospital stays, and a low risk of VTE. The important task for the clinician is to identify patients with a sufficiently high risk of symptomatic VTE to warrant LMWH prophylaxis. Despite differences in study selection and data extraction, our study shows results similar to a recent meta‐analysis.Keywords
This publication has 23 references indexed in Scilit:
- Hospitals’ compliance with prophylaxis guidelines for venous thromboembolismAmerican Journal of Health-System Pharmacy, 2007
- Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk scoreJournal of Thrombosis and Haemostasis, 2004
- Validation of a clinical guideline on prevention of venous thromboembolism in medical inpatients: a before‐and‐after study with systematic ultrasound examinationJournal of Internal Medicine, 2004
- Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgeryBritish Journal of Surgery, 2004
- Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory diseaseAmerican Heart Journal, 2003
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseasesThe Lancet, 1996
- The bleeding severity index: Validation and comparison to other methods for classifying bleeding complications of medical therapyJournal of Clinical Epidemiology, 1988
- Prevention of Deep Vein Thrombosis in Elderly Medical In-Patients by a Low Molecular Weight Heparin: A Randomized Double-Blind TrialPathophysiology of Haemostasis and Thrombosis, 1986
- Comparison of Sodium and Calcium Heparin in Prevention of Venous ThromboembolismAustralian and New Zealand Journal of Medicine, 1982